mg comp./Erlotinib 100 mg comp./Bevacizumab/Rituximab 500mg sol inj./Trastuzumab

ID 447005 · Portal BASE
Price
Base Price
€0 .00
Effective Price
€571,305 .00
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33652000
Location
Portugal, Faro, Portimão
Bidder Count
—
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Company
Dates
Publication
13 Jan 2012
Celebration
13 Jan 2012
Contracting Entity
Centro Hospitalar do Barlavento Algarvio, EPE
NIF 507062540
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
399
Supplier
93
Number of Awards
10
Rule
A1 repeat direct award: 10 awards within 36 months
Detected 2026-03-06